Integrity When Complexity is High
Precision execution for viral vector manufacturing.
Gene therapy manufacturing introduces complex and sensitive bioprocessing challenges—tight operating windows, fragile vectors, and low tolerance for variability. Focused on moving gene therapy programs forward, ABEC offers integrated bioprocess solutions engineered to support consistent execution, protect process integrity, and enable confident scale-out.
ENGINEERED FOR VECTOR INTEGRITY
ABEC gene therapy solutions are designed to support the specific demands of viral vector production. From controlled mixing and mass transfer to closed-system architectures and automation, every element is engineered to protect vector quality and process performance.
BUILT FOR PREDICTABLE SCALE-OUT
Gene therapy manufacturing often scales by replication rather than by volume. ABEC bioprocess systems are designed to preserve process behavior across multiple units—supporting consistent performance as capacity expands.
INTEGRATED TO REDUCE PROCESS RISK
With turnkey engineering, fabrication, automation, and validation, ABEC minimizes the handoffs that can introduce variability. The result? More predictable execution from installation through operation.
ALIGNED WITH EVERY EVOLUTION
ABEC collaborates closely with each of our customers to engineer biopharma manufacturing systems that meet today’s clinical needs while supporting future production strategies—without forcing redesign as programs grow and expand.
PROVEN TO DELIVER
RELIABILITY UNDER PRESSURE
Gene therapy success depends on precise execution. Small deviations in process conditions can impact vector yield, potency, and consistency. Repeatability is essential as programs advance. ABEC helps gene therapy manufacturers move forward with confidence through engineered systems designed to minimize variability, reduce risk, and deliver repeatable performance across development and scale-out operations.
TRUSTED IN ENVIRONMENTS WHERE
PRECISION IS CRITICAL
ABEC solutions support gene therapy production in environments where precision
and repeatability are essential.
Customized single-use gene therapy systems designed for predictable performance and optimized scale-out strategies.
LEARN MORE >Robust stainless-steel platforms supporting downstream operations, expansion phases, and sustained gene therapy manufacturing.
LEARN MORE >Hybrid gene therapy production approaches that balance single-use flexibility with long-term operational stability as programs expand.
LEARN MORE >Closed, automated bioreactor systems designed to support reproducible viral vector production workflows.
LEARN MORE >Proven modeling and validation programs that help minimize scale-out risk and confirm process behavior early.
LEARN MORE >Integrated bioprocess automation solutions that support consistent execution and reduce operational variability.
LEARN MORE >Designed for Today’s Programs—and Tomorrow’s Therapies
Gene therapy manufacturers rely on ABEC because performance must hold as complexity increases.
From early clinical production through expanded manufacturing networks, ABEC bioprocessing solutions are engineered to support repeatability, reduce risk, and adapt as gene therapy programs evolve.